Plain-English translation of NCT07317115 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a new surgical procedure using magnetic compression to reroute part of your small intestine works as well as —an injectable medication—for improving type 2 diabetes and supporting weight loss in adults with obesity. You would be randomly assigned to receive either the surgery or the medication, and researchers will compare how well each treatment helps control blood sugar and weight over time.
Many people with obesity and type 2 diabetes struggle to manage their condition with diet and exercise alone. This trial exists to see whether this newer surgical approach might be a good alternative to the medication for people who need additional help.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to either receive the magnetic surgery procedure or to take the injectable medication regularly. You will need to visit the clinic for evaluations to check your blood sugar, weight, and overall health. The study will track how well your diabetes improves and how your weight changes over the study period, with regular follow-up appointments to monitor your progress.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Canada
Sponsor
GT Metabolic Solutions, Inc.
Enrollment target
~20 participants
Started
March 2026
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lisa Griffin Vincent, PhD, MA
GT Metabolic Solutions, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.